ArticleMolecular cancer2024

Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma.

XiaoChang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.